In the news: Chinese capital market turmoil discussed, GSK scientists steal trade secrets and Shanghai's VC compensation plan under fire
January 27, 2016 | BY
Katherine JoThis week China's stocks and capital outflows were analyzed, ex-Glaxo employees were charged with cancer drug data theft, investors criticized a local venture capital investment incentive and a probe into new-energy auto subsidies fraud began
China's stocks declined to a 13-month low this week – the latest example of the highly volatile start to the year for the country's financial markets. Investors are concerned about stability – and they appear to be fast losing confidence – in the ability of Chinese authorities to combat the turmoil. The unpredictability of policymakers has further called to question whether it is really the government's intention to give greater say to market forces, regardless of the currency's acceptance into the IMF's SDR basket. The pent-up desire of domestic investors to move their money offshore is in danger of coming to the fore when capital controls are eased. It is estimated that, in 2015, even with strict capital controls in place, $1 trillion left China – six or seven times more than the amount that left the country the previous year. If China really is going to ease controls further, outflows in 2016 could be off the charts and lead to the very financial instability that China is now trying to fight.
More from CLP:
Five people, including two former GlaxoSmithKline researchers, were charged with theft of trade secrets on drugs for cancer and other serious diseases from the British drugmaker, the U.S. Attorney's Office in Philadelphia said last Wednesday. Two of the individuals (one a senior-level manager), Chinese nationals who worked as scientists in GSK's Upper Merion Township research facility, reportedly downloaded confidential information from the company's network and sent it to their co-conspirators, who formed a corporation in China called Renopharma, allegedly to market and sell the stolen trade secrets that could be used to reproduce GSK products and drugs in development. This isn't the first incident in the U.S. involving a Chinese citizen taking trade secrets back to their country. In fact, the first parallel enforcement in China and the U.S. for trade secret violations involved RF Micro Devices in 2013, which was also the first case where the owner pursued criminal prosecution on top of civil litigation in both jurisdictions. Regulations now have a long-arm reach, and the criminal liability and severity of punishments have increased for violating private data. We discussed how businesses can protect themselves from misappropriation here, and how to litigate in China here.
More from CLP:
Five charged with theft of GSK cancer drug secrets Understanding the courts' approach to trade secret cases Handling disputes, trade secrets, as data rules tighten Akzo Nobel interview: How IP leverages international companies MediaTek interview: Targeting trade secrets and the courts – Taiwan Focus
Investors have criticized a Shanghai government plan to encourage innovation and private venture capital (VC) investment by compensating VC firms for losses from investing in high-tech startups. The policy is set in a regulation dated December 29. It allows a VC to ask for a payout of 30% to 60%, depending on size and revenue, of the shortfall, if the sale of its stake in a startup fails to cover the original investment. The cap is Rmb6 million for firms and Rmb3 million for individuals. One private equity investor said this will have a “disastrous” impact on fundamental capital market principles, which involve matching risk and return. VC investments are extremely risky and limited to very few people and institutions, and the negative consequences of using public money to compensate losses will be unimaginable, he said. Another issue is that the regulation's loopholes and lack of clear standards on calculating losses. China has recently rolled out a series of tax breaks for R&D, VC and high-tech startups, and although such incentives can spur innovation, providing investors a monetary safety net by providing compensation in case of failure could be a huge risk to everyone involved. VC investors are already extremely selective, but this may result in the taking on of higher – and ill-advised – risk. The focus should be on things such as boosting IP enforcement and legal protection, rather than on the encouragement of unbridled lending.
More from CLP:
Announcement on Issues Relevant to Enterprise Income Tax on Legal Person Partners of Venture Capital Firms Organized as Limited Partnerships Circular on Expanding the Implementation of Relevant Pilot Tax Policies of National Innovation Demonstration Zones on a Nationwide Basis R&D tax breaks ease corporate burdens China First Capital interview: Cashing in and cashing out
China will investigate reports that companies are committing fraud to obtain state subsidies for new-energy vehicle sales. The aim is to ensure that the billions of dollars spent on promoting emission-free autos are going to legitimate makers. The Ministry of Finance (MOF), State Administration for Industry and Commerce (SAIC), Ministry of Science and Technology and the National Development and Reform Commission (NDRC) will begin a probe and severely punish, blacklist and publicize violators, an official said. Local media have reported on scams including companies assembling and selling poor-quality vehicles to shell companies to obtain state subsidies. The authorities are right to crack down. With pollution levels as high as they are in cities like Beijing and Shanghai, the last thing that China wants is to allow the illegal acts of a few to scupper the fledgling green-vehicle industry.
More from CLP:
This premium content is reserved for
China Law & Practice Subscribers.
A Premium Subscription Provides:
- A database of over 3,000 essential documents including key PRC legislation translated into English
- A choice of newsletters to alert you to changes affecting your business including sector specific updates
- Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
Already a subscriber? Log In Now